The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A prospective, phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumors.
Silvia Park
No relevant relationships to disclose
Keunchil Park
No relevant relationships to disclose
Myung-ju Ahn
No relevant relationships to disclose
Jin Seok Ahn
No relevant relationships to disclose
Jong-Mu Sun
No relevant relationships to disclose
Hee Kyung Ahn
No relevant relationships to disclose
Su Jin Lee
No relevant relationships to disclose
Chi Hoon Maeng
No relevant relationships to disclose
Deok Won Hwang
No relevant relationships to disclose